Anzeige
Mehr »
Login
Dienstag, 07.02.2023 Börsentäglich über 12.000 News von 679 internationalen Medien
Noch einmal große Einstiegschance!? - Warum genau jetzt aktiv werden…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12FAG ISIN: US0008991046 Ticker-Symbol:  
NASDAQ
06.02.23
22:00 Uhr
3,710 US-Dollar
-0,050
-1,33 %
1-Jahres-Chart
ADMA BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
ADMA BIOLOGICS INC 5-Tage-Chart

Aktuelle News zur ADMA BIOLOGICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.01.ADMA BIOLOGICS, INC. - 8-K, Current Report1
17.01.ADMA Biologics gains as guidance exceeds consensus1
17.01.ADMA Biologics, Inc.: ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance-
ADMA BIOLOGICS Aktie jetzt für 0€ handeln
07.01.ILMN, CARA and ADMA are among after hour movers8
15.12.22Looking Into ADMA Biologics' Return On Capital Employed6
13.12.22Adma gets FDA approval for room temperature storage of Asceniv, Bivigam2
13.12.22ADMA Biologics, Inc.: ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV & BIVIGAM-
09.12.22ADMA Biologics, Inc.: ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares213RAMSEY, N.J. and BOCA RATON, Fla., Dec. 09, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to...
► Artikel lesen
07.12.22ADMA Biologics stock dips after pricing ~$60M share offering4
07.12.22ADMA Biologics, Inc.: ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock235RAMSEY, N.J. and BOCA RATON, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to manufacturing...
► Artikel lesen
06.12.22ADMA Biologics down 7% following stock offering1
06.12.22ADMA BIOLOGICS, INC. - 8-K, Current Report1
06.12.22ADMA Biologics, Inc.: ADMA Biologics Announces Proposed Public Offering of Common Stock205RAMSEY, N.J. and BOCA RATON, Fla., Dec. 06, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to...
► Artikel lesen
06.12.22ADMA Biologics, Inc.: ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate146RAMSEY, N.J. and BOCA RATON, Fla., Dec. 06, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) ("ADMA" or the "Company"), an end-to-end commercial biopharmaceutical company dedicated to...
► Artikel lesen
10.11.22ADMA Biologics hits 52-week high after strong Q3 beat3
09.11.22ADMA Biologics, Inc.: ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update2043Q2022 Total Revenues Were $41.1 Million, a 99% Y-o-Y Increase Grew 3Q2022 Gross Profit to $9.7 Million, a $9.3 Million Y-o-Y Increase Raising FY 2022 Total Revenue Guidance to $145...
► Artikel lesen
08.11.22A Preview Of ADMA Biologics' Earnings2
02.11.22ADMA Biologics, Inc.: ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022-
31.10.22Adma stock rises on FDA approval of North Carolina-based plasma collection center1
31.10.22ADMA Biologics, Inc.: ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC-
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1